Norman Sharpless, director of the National Cancer Institute, has been selected to serve as the acting commissioner for the FDA, following the resignation of Scott Gottlieb, MD, earlier this month.
Norman Sharpless, director of the National Cancer Institute, has been selected to serve as the acting commissioner for the FDA, following the resignation of Scott Gottlieb, MD, earlier this month.
Norman Sharpless, director of...